Dawn Phenomenon

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-10-21
Clinical Trial Update: Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon [Phase 3]
Phase 3 trial comparing Lantus (insulin glargine) with NPH insulin in people with Type 1 diabetes experiencing Dawn phenomenon; study comple…